National High Level Hospital Clinical Research Funding(No.2024-NHLHCRF-YS-01);Capital’s Founds for Health Improvement and Research(No.2022-1-4062);Beijing Research Ward Construction Clinical Research Project(No.2022-YJXBF-04-03);Science Foundation of China-Japan Friendship Hospital(No.2020-HX-40);National Natural Science Foundation of China(No.82270352);National High Level Hospital Clinical Research Funding(No.2024-NHLHCRF-JBGS-WZ-06);Chinese Society of Cardiology’s Foundation(No.CSCF2021B02);National Key Clinical Specialty Construction Project(No.2020-QTL-009)
Background:The available evidence regarding the benefits of percutaneous coronary intervention(PCI)on patients receiving dialysis with coronary artery disease(CAD)is limited and inconsistent.This study aimed to evalua...
The prevalence of chronic kidney disease(CKD)in China was 8.2%in 2018-2019.[1]CKD may progress to end-stage kidney disease(ESKD),necessitating kidney replacement treatment such as dialysis or kidney transplantation,[2...
supported by grants from the National Natural Science Foundation of China(Nos.82200820,81970599 and 82170737);Guangzhou Science and Technology Project(No.202201011483);Key Laboratory of National Health Commission,and Key Laboratory of Nephrology,Guangdong Province,Guangzhou,China(Nos.2002B60118 and 2020B1212060028);and 5010 Clinical Program of Sun Yat-Sen University(No.2017007);and National Key Research and Development Project of China(No.2021YFC2501302).
Background: The clinical importance of hypokalemia is likely underrecognized in Chinese dialysis patients, and whether its clinical effect was mediated by serum albumin is not fully elucidated. This study aimed to exp...
Peking University Special Fund for COVID-19 Prevention and Control(No.PKU2020PKYZX001)。
To the Editor:The coronavirus disease2019(COVID-19)outbreak developedinto a pandemic.Patientsundergoing hemodialysis(HD)are more susceptible to COVID-19,and isolating patients undergoing HD after exposure are extremel...
funded by the National Natural Science Foundation of China(No.82000702).
To the Editor:Peritoneal dialysis(PD)is a well-established renal replacement therapyin end-stage renal disease(ESRD)patients.Despite significant advances in technologies in recent decades,the mortality of PD patients ...
National Clinical Research Center for Geriatrics,the West China Hospital,Sichuan University(No.Z2018B10);Key Project of Research and Development of Science and Technology Department of Sichuan Province(No.2018FZ0102);Science and Technology Achievement Transformation Fund of West China Hospital of Sichuan University(No.CGZH19006);World-Class University Construction Fund of Sichuan University(No.2040204401012)。
Chronic fluid overload(FO)is a well-known factor which contributes to the high morbidity and mortality of patients undergoing hemodialysis(HD).[1]Higher blood pressure(BP)is commonly associated with overload volume.[1...
This work was supported by grants from the Young Scientific and Academic Leaders Training Program of Sichuan University(No.0082604151001/035);Clinical Research Incubation Project of West China Hospital of Sichuan University(No.2018HXFH055);West China Nursing Discipline Development Special Fund Project,Sichuan University(No.HXHL19015);and Projects from Scientific and Technological Department of Sichuan Province,China(No.2019YFS0289).
To the Editor:Chronic kidney disease(CKD)is rapidly becoming a major public disease burden,affecting approximately 11%to 13%of the general population.[1]Its related treatments severely influence the physical,psycholog...
supported by a grant of Sichuan Medical Association Scientific Research Project(No.2017SHD001).
Hemodialysis(HD)is a crucial renal replacement therapy for patients with end-stage renal disease.Despite improvements in dialysis technology,mortality for maintenance HD(MHD)patients remains high.To improve the qualit...
Chinese National Renal Data System111 is the first national database for Chinese hemodialysis(HD)population,but unfortunately,data of monitoring frequency of laboratory markers were not well recorded,and therapeutic i...
This work was supported by grants from the Global support for the ongoing DOPPS Programs without restriction on publications by a variety of funders(For details see https://www.dopps.org/AboutUs/Support.aspx);Dr.Shuchi Anand is supported by U.S.National Institute of Diabetes,and Digestive and Kidney Diseases(No.NIDDK K-235K23DK101826-03);Dr.Jun Wang is supported by the National Natural Science Foundation of China(No.81470972).
Background:Despite a growing population of patients starting hemodialysis in China,little is known about markers of mineral bone disease(MBD)and their management.We present data on prevalence and correlates of hypocal...